Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Eli Lilly could be the next stock to cross $1 trillion, says Jim Cramer
07:16pm, Monday, 26'th Feb 2024
'Mad Money' host Jim Cramer looks at the current class of $1 trillion stocks and looks at what stocks could be poised to join the group.
Zealand's obesity drug shouldn't disrupt Novo Nordisk-Eli Lilly leadership: Mizuho's Jared Holz
06:32pm, Monday, 26'th Feb 2024
Jared Holz, Mizuho, joins 'Fast Money' to talk obesity drugmakers after a new study out of Zealand Pharma analyzed the impact of GLP-1s on liver disease.
Future Juggernauts: The Next 7 Trillion Dollar Companies to Buy Now
02:10pm, Monday, 26'th Feb 2024
Investors learned an important lesson in 2023: investing in the biggest companies and their stocks is a surefire way to capture strong gains. The Magnificent 7 – all of which are trillion dollar sto
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
11:29am, Monday, 26'th Feb 2024
Pharma stocks and massive potential are synonymous. With horrible diseases like cancer, diabetes, and heart disease still a mile away from developing a cure, drugs that address these conditions comman
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
10:06am, Monday, 26'th Feb 2024
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novo Nordisk and Eli Lilly rival soars 26% after promising weight-loss drug results
05:32am, Monday, 26'th Feb 2024
Zealand Pharma's Phase 2 trial was an "uniquivocal win" for a drug that can treat both liver disease and obesity, analysts said.
Could Eli Lilly Stock Help You Become a Millionaire?
06:11am, Friday, 23'rd Feb 2024
Eli Lilly's sales and profits are likely to be boosted by new treatments for diabetes, weight loss, and potentially Alzheimer's. The stock's valuation is pricey, but it could look cheap years from now
Why Eli Lilly Stock Was Feeling Sickly on Wednesday
05:56pm, Wednesday, 21'st Feb 2024
An analyst downgraded the pharmaceutical mainstay's shares. He now feels the company is only a hold; previously, he tagged it as worthy of a buy.
3-Stock Lunch: AMZN, WBA & LLY
04:17pm, Wednesday, 21'st Feb 2024
Boris Schlossberg, BK Asset Management managing director of FX Strategy, joins 'Power Lunch' to discuss stock plays for three stocks including; Amazon.com, Walgreens and Eli Lilly.
Wall Street Favorites: 7 Growth Stocks With Strong Buy Ratings for February 2024
02:32pm, Wednesday, 21'st Feb 2024
Analysts love growth stocks, especially those that continue to register strong earnings growth and dominate the markets in which they compete. In fact, I discuss a few of them below.
Eli Lilly Has More Than an Ozempic Competitor -- Much More
06:39am, Wednesday, 21'st Feb 2024
Eli Lilly is enjoying impressive revenue growth fueled by high demand for its diabetes treatments. However, the company also develops medications for cancer, plaque psoriasis, and obesity.
3 Top Sectors Investment Dollars Are Pouring Into Now: February 2024
03:45pm, Tuesday, 20'th Feb 2024
Top sectors are tough to pin down in advance. Far more often, we look backward at market performance to identify trends and top sectors.
Top 7 Contenders to Join the Trillion-Dollar Club
01:54pm, Tuesday, 20'th Feb 2024
By hitting the elusive $3 trillion mark in valuation last month, Microsoft (NASDAQ: MSFT ) reignited the debate over trillion-dollar companies. This monumental achievement, fueled by the burgeoning
5 Best-Performing S&P 500 Stocks Halfway Through Q1
09:11am, Tuesday, 20'th Feb 2024
Nvidia (NVDA), Eli Lilly (LLY), Meta Platforms (META), Uber Technologies (UBER) and Ralph Lauren (RL) are the five best-performing stocks in the S&P 500.
These stocks are overbought and may crash soon
04:28am, Tuesday, 20'th Feb 2024
During the holiday period, stock markets experienced a lull with minimal activity. However, certain stocks garnered investor attention, pushing them into the ‘overbought' territory, potentially pavi
